Indications of Intra-Vitreal Anti-VEGF Abd Zeena Adnan1,* 1Surgery Department Ophthalmology Unit, College of Medicine, Al-Nahrain University, Baghdad, Iraq *Corresponding Author: Zeena Adnan Abd, MBChB, FABMS, ICO Surgery Department, Ophthalmology Unit, College of Medicine, Al-Nahrain University, Baghdad, Iraq, Email: zeenaadnan@yahoo.com
Online published on 23 December, 2019. Abstract Background Anti-vascular endothelial growth factors are being widely used in the field of ophthalmology, with a variety of indications which are expanding over time Aim To assess the frequency of different types of diseases treated with anti-VEGF agents. Method A cross sectional study involving 100 patients, data included: age, gender, indication for anti-VEGF & presence or absence of diabetes. Results The mean age was 57.7 years males represent 61% while females 39%, and the most common indication for intravitreal anti-VEGF was diabetic maculopathy with clinically significant macular odema (csmo) which represent 80% of cases, the second and third indications were vitreous hemorrhage 6% and wet type age related macular degeneration (AMD) 5%. Diabetes was present in 94% of all cases. Conclusion Diabetes is the major risk factor causing varieties of retinal diseases that need intravitreal anti-VEGF agents, among which clinically significant macular odema is the most common pathology. Top Keywords Anti-VEGF, Clinically significant macular odema, diabetes. Top |